Literature DB >> 10963680

Androgen-induced proliferative quiescence in prostate cancer cells: the role of AS3 as its mediator.

P Geck1, M V Maffini, J Szelei, C Sonnenschein, A M Soto.   

Abstract

In the prostate gland of adult mammals, most epithelial cells are in a state of proliferative quiescence. Androgens regulate this effect by inducing cell cycle arrest in the G(0)/G(1) phase. Potential mediators of this androgen-induced proliferative shutoff were identified by means of subtracted cDNA libraries. The expression pattern of one of these sequences, AS3, strongly correlated with the expression of the androgen-induced proliferative shutoff both temporally and dosewise. The AS3 gene is located on chromosome 13 q12.3, in close proximity to the BRCA2 gene. The loss of chromosomal regions where AS3 alleles are located correlates with various human cancers, including prostate. The biological effect of AS3 was tested in two stable cell lines, one expressing sense and another expressing antisense AS3 constructs, both under tetracycline regulation. S9 cells were obtained by retroviral infection with virions containing a tetracycline-regulated sense AS3 construct. In these cells, sense AS3 was negatively regulated by tetracycline. Tetracycline withdrawal increased the expression of AS3 mRNA and protein. The expression of tetracycline-regulated AS3 resulted in inhibition of cell proliferation. A4 cells were obtained by retroviral infection with virions containing a tetracycline-regulated antisense AS3 construct. Vector-driven expression of antisense-AS3 blocked the induction of androgen-induced endogenous AS3 mRNA and blocked the inhibitory effect of androgens on cell proliferation. Tetracycline-regulated expression of the empty vector control had no effect on cell proliferation. These experiments strongly suggest that AS3 is a mediator of the androgen-induced proliferative shutoff.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963680      PMCID: PMC27796          DOI: 10.1073/pnas.97.18.10185

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Early gene expression during androgen-induced inhibition of proliferation of prostate cancer cells: a new suppressor candidate on chromosome 13, in the BRCA2-Rb1 locus.

Authors:  P Geck; J Szelei; J Jimenez; C Sonnenschein; A M Soto
Journal:  J Steroid Biochem Mol Biol       Date:  1999-01       Impact factor: 4.292

2.  Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

Authors:  K Ishikawa; T Nagase; M Suyama; N Miyajima; A Tanaka; H Kotani; N Nomura; O Ohara
Journal:  DNA Res       Date:  1998-06-30       Impact factor: 4.458

3.  Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells.

Authors:  P Geck; J Szelei; J Jimenez; T M Lin; C Sonnenschein; A M Soto
Journal:  J Steroid Biochem Mol Biol       Date:  1997 Nov-Dec       Impact factor: 4.292

4.  Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride.

Authors:  Y Umekita; R A Hiipakka; J M Kokontis; S Liao
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia.

Authors:  J A Garcia-Marco; C Caldas; C M Price; L M Wiedemann; A Ashworth; D Catovsky
Journal:  Blood       Date:  1996-09-01       Impact factor: 22.113

6.  Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response.

Authors:  A M Soto; T M Lin; K Sakabe; N Olea; D A Damassa; C Sonnenschein
Journal:  Oncol Res       Date:  1995       Impact factor: 5.574

7.  Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor.

Authors:  J Szelei; J Jimenez; A M Soto; M F Luizzi; C Sonnenschein
Journal:  Endocrinology       Date:  1997-04       Impact factor: 4.736

8.  Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.

Authors:  J M Kokontis; N Hay; S Liao
Journal:  Mol Endocrinol       Date:  1998-07

9.  Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13.

Authors:  J Gudmundsson; G Johannesdottir; J T Bergthorsson; A Arason; S Ingvarsson; V Egilsson; R B Barkardottir
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

10.  Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation.

Authors:  J Kokontis; K Takakura; N Hay; S Liao
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

View more
  32 in total

1.  The D13S171 marker, misannotated to BRCA2, links the AS3 gene to various cancers.

Authors:  P Geck; C Sonnenschein; A M Soto
Journal:  Am J Hum Genet       Date:  2001-08       Impact factor: 11.025

2.  BimD/SPO76 is at the interface of cell cycle progression, chromosome morphogenesis, and recombination.

Authors:  D van Heemst; E Kafer; T John; C Heyting; M van Aalderen; D Zickler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

Review 3.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

4.  APRIN is a unique Pds5 paralog with features of a chromatin regulator in hormonal differentiation.

Authors:  Maricel Maffini; Viktoria Denes; Carlos Sonnenschein; Ana Soto; Peter Geck
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-12       Impact factor: 4.292

5.  Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.

Authors:  Myles C Hodgson; Long-jiang Shao; Anna Frolov; Rile Li; Leif E Peterson; Gustavo Ayala; Michael M Ittmann; Nancy L Weigel; Irina U Agoulnik
Journal:  Cancer Res       Date:  2011-01-11       Impact factor: 12.701

6.  Overexpression of APRIN inhibits differentiation and proliferation and promotes apoptosis in P19 embryonal carcinoma cells.

Authors:  Xiang Zhou; Xiangqing Kong; Weiting Xu; Jianchang Chen
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

Review 7.  Use of testosterone replacement therapy in patients with prostate cancer.

Authors:  Tanya B Dorff; Nicholas J Vogelzang
Journal:  Curr Urol Rep       Date:  2011-06       Impact factor: 3.092

8.  Ligand activation of the androgen receptor downregulates E-cadherin-mediated cell adhesion and promotes apoptosis of prostatic cancer cells.

Authors:  Joanna Nightingale; Khurram S Chaudhary; Paul D Abel; Andrew P Stubbs; Hanna M Romanska; Stephen E Mitchell; Gordon W H Stamp; El-Nasir Lalani
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

Review 9.  Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption.

Authors:  Laura N Vandenberg; Maricel V Maffini; Carlos Sonnenschein; Beverly S Rubin; Ana M Soto
Journal:  Endocr Rev       Date:  2008-12-12       Impact factor: 19.871

10.  Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer.

Authors:  Nima Sharifi; Elaine M Hurt; Suneetha B Thomas; William L Farrar
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.